Multifunctional antitumor magnetite/chitosan-L-glutamic acid (core/shell) nanocomposites

Journal of Nanoparticle Research

Volumn 13, Issue 9, 2011, Pages 4311-4323

  Santos, Daniela P ^a   Ruiz, M Adolfina ^b   Gallardo, Visitación ^b   Zanoni, Maria Valnice B ^a   Arias, José L ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Biodegradable nanoparticle; Cancer; Doxorubicin; Hyperthermia; Magnetically responsive drug nanocarrier; Multifunctional nanoformulation; Nanomedicine

Indexed keywords

BIODEGRADABLE NANOPARTICLE; CANCER; DOXORUBICIN; HYPERTHERMIA; MULTIFUNCTIONAL NANOFORMULATION; NANOCARRIERS; NANOMEDICINES;

ADSORPTION; AMINO ACIDS; CHEMICAL MODIFICATION; CHEMOTHERAPY; DISEASES; DRUG DELIVERY; HYPERTHERMIA THERAPY; MEDICAL NANOTECHNOLOGY; NANOCOMPOSITES; NANOPARTICLES; SYNTHESIS (CHEMICAL); TUMORS;

DRUG PRODUCTS;

CHITOSAN; DOXORUBICIN; GLUTAMIC ACID; MAGNETIC NANOPARTICLE; MAGNETITE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; DRUG ADSORPTION; ELECTRON MICROSCOPY; HYPERTHERMIA; NEOPLASM; PRIORITY JOURNAL; SLOW DRUG RELEASE; SPECTROPHOTOMETRY; SUSTAINED DRUG RELEASE; THERMODYNAMICS;

EID: 81055156324     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-011-0378-z     Document Type: Article

References (50)

1. Ang KL, Venkatraman S, Ramanujan RV (2007) Magnetic PNIPA hydrogels for hyperthermia applications in cancer therapy. Mater Sci Eng C 27:347-351. doi:10.1016/j. msec.2006.05.027
2. Arias JL (2008) Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems. Molecules 13:2340-2369. doi:10.3390/molecules13102340
3. Arias JL (2011) Drug targeting strategies in cancer treatment: an overview. Mini Rev Med Chem 11:1-17. doi:10.2174/ 138955711793564024
4. Arias JL, Gallardo V, Gómez-Lopera SA, Plaza RC, Delgado AV (2001) Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. J Control Release 77:309-321. doi:10.1016/S0168-3659(01) 00519-3
5. Arias JL, Gallardo V, Linares-Molinero F, Delgado AV (2006) Preparation and characterization of carbonyl iron/poly (butylcyanoacrylate) core/shell nanoparticles. J Colloid Interface Sci 299:599-607. doi:10.1016/j.jcis.2006.03. 005
6. Arias JL, Gallardo V, Ruiz MA, Delgado AV (2007) Ftorafur loading and controlled release from poly(ethyl-2-cyanoacrylate) and poly(butylcyanoacrylate) nanospheres. Int J Pharm 337:282-290. doi:10.1016/j.ijpharm.2006.12.023
7. Arias JL, Reddy LH, Couvreur P (2008) Magnetoresponsive squalenoyl gemcitabine composite nanoparticles for cancer active targeting. Langmuir 24:7512-7519. doi:10.1021/ la800547s
8. Arias JL, Reddy LH, Couvreur P (2009) Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine. J Drug Target 17:586-598. doi:10.1080/10611860903105739
9. Arias JL, Martínez-Soler GI, López-Viota M, Ruiz MA (2010a) Formulation of chitosan nanoparticles loaded with metronidazole for the treatment of infectious diseases. Lett Drug Des Discov 7:70-78. doi:10.2174/ 157018010790225831
10. Arias JL, López-Viota M, Gallardo V, Ruiz MA (2010b) Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur. Drug Dev Ind Pharm 36:744-750. doi:10.3109/03639040903517914
11. Bodnar M, Hartmann JF, Borbely J (2005) Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 6:2521-2527. doi:10.1021/bm0502258
12. Campbell RB (2007) Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat. Nanomedicine 2:649-652. doi:10.2217/17435889. 2.5.649
13. Gaihre B, Khil MS, Lee DR, Kim HY (2009) Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study. Int J Pharm 365:180-189. doi:10.1016/j.ijpharm.2008.08.020
14. Huber DL (2005) Synthesis, properties, and applications of iron nanoparticles. Small 1:482-501. doi:10.1002/smll. 200500006
15. Iannone A, Magin RL, Walczack T, Federico M, Swartz HM, Tomasi A, Vannini V (1991) Blood clearance of dextran magnetite particles determined by a noninvasive in vivo ESR method. Magn Reson Med 22:435-442. doi:10.1002/ mrm.1910220251
16. Illum L (1998) Chitosan and its use as a pharmaceutical excipient. Pharm Res 15:1326-1331. doi:10.1023/A: 1011929016601
17. Ito A, Shinkai M, Honda H, Kobayashi T (2005) Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 100:1-11. doi:10.1263/jbb.100.1
18. Jordan A, Scholz R, Maier-Hauff K, Johannsen M, Wust P, Nadobny J, Schirra H, Schmidt H, Deger S, Loening S, Lanksch W, Felix R (2001) Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J Magn Magn Mater 225:118-126. doi:10.1016/S0304-8853(00)01239-7
19. Kalele S, Narain R, Krishnan KM (2009) Probing temperaturesensitive behavior of pNIPAAm-coated iron oxide nanoparticles using frequency-dependent magnetic measurements. J Magn Magn Mater 321:1377-1380. doi:10. 1016/j.jmmm.2009.02.134
20. Kallay N, Torbić Ž, Golić M, Matijević E (1991) Determination of the isoelectric points of severalmetals by an adhesionmethod. J Phys Chem 95:7028-7032. doi:10.1021/j100171a056
21. Lao LL, Ramanujan RV (2004) Magnetic and hydrogel composite materials for hyperthermia applications. J Mater Sci Mater Med 15:1061-1064. doi:10.1023/B:JMSM. 0000046386.78633.e5
22. Laurent S, Forge D, Port M, Roch A, Robic C, Elst LV, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108: 2064-2110. doi:10.1021/cr068445e
23. Llovet MI, Egea MA, Valero J, Alsina MA, García ML, Chauvet A (1995) Methotrexate-loaded nanoparticles: analysis of drug content and study of the matrix structure. Drug Dev Ind Pharm 21:1761-1771. doi:10.3109/ 03639049509069263
24. Lyklema J (2002) The role of surface conduction in the development of electrokinetics. In: Delgado AV (ed) Interfacial electrokinetics and electrophoresis. Marcel Dekker, New York, pp 87-98
25. Lyon RJP (1967) Infrared absorption spectroscopy. In: Zussman J (ed) Physical methods in determinative mineralogy. Academic Press, London/New York, pp 371-399
26. Massart R (1981) Preparation of aqueous magnetic liquids in alkaline and acidicmedia. IEEE Trans Magn 17:1247-1248. doi:10.1109/TMAG.1981.1061188
27. Meers P (2001) Enzyme-activated targeting of liposomes. Adv Drug Deliv Rev 53:265-272. doi:10.1016/S0169-409X (01)00205-8
28. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185-229. doi:10.1124/pr.56.2.6
29. Müller RH, Maaßen S, Weyhers H, Specht F, Lucks JS (1996) Cytotoxicity of magnetite-loaded polylactide, polylactide/ glycolide particles and solid lipid nanoparticles. Int J Pharm 138:85-94. doi:10.1016/0378-5173(96) 04539-5
30. Needham D, Dewhirst MW (2001) The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev 53:285-305. doi:10.1016/S0169-409X(01)00233-2
31. Needham D, Anyarambhatla G, Kong G, Dewhirst MW (2000) A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res 60:1197-1201
32. Nordtveit RJ, Vårum KM, Smidsrød O (1994) Degradation of fully water-soluble, partially N-acetylated chitosans with lysozyme. Carbohydr Polym 23:253-260. doi:10.1016/ 0144-8617(94)90187-2
33. O'Brien RW, White LR (1978) Electrophoretic mobility of a spherical colloidal particle. J Chem Soc Faraday Trans 2:1607-1626. doi:10.1039/ F29787401607
34. Okon E, Pouliquen D, Okon P, Kovaleva ZV, Stepanova TP, Lavit SG, Kudryavtsev BN, Jallet P (1994) Biodegradation of magnetite dextran nanoparticles in the rat: a histologic and biophysical study. Lab Invest 71:895-903
35. Papadimitriou S, Bikiaris D, Avgoustakis K, Karavas E, Georgarakis M (2008) Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr Polym 73:44-54. doi:10.1016/j.carbpol.2007.11.007
36. Pitt CG (1990) The controlled parenteral delivery of polypeptides and proteins. Int J Pharm 59:173-196. doi:10. 1016/0378-5173(90)90108-G
37. Plaza RC, Arias JL, Espín M, Jiménez ML, Delgado AV (2002) Aging effects in the electrokinetics of colloidal iron oxides. J Colloid Interface Sci 245:86-90. doi: 10.1006/jcis.2001.7964
38. Purushotham S, Ramanujan RV (2010) Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. Acta Biomater 6:502-510. doi:10.1016/j.actbio. 2009.07.004
39. Rapoport N (2004) Combined cancer therapy by micellarencapsulated drug and ultrasound. Int J Pharm 277: 155-162. doi:10.1016/j.ijpharm.2003.09.048
40. Regazzoni AE, Blesa MA, Maroto AJG (1983) Interfacial properties of zirconium dioxide and magnetite in water. J Colloid Interface Sci 91(2):560-570. doi:10.1016/ 0021-9797(83)90370-3
41. Ruiz MA, Gallardo V, Arias JL, Delgado A (2003) Effect of latex and plasticizer concentration on glucocorticoid release from ointments. Pharm Ind 65:454-457
42. Singh J, Dutta PK, Dutta J, Hunt AJ, Macquarrie DJ, Clark JH (2009) Preparation and properties of highly soluble chitosan-L-glutamic acid aerogel derivative. Carbohydr Polym 76:188-195. doi:10.1016/j.carbpol.2008.10.011
43. Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S (2004) Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274:1-33. doi:10.1016/j.ijpharm.2003.12.026
44. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 70:1-20. doi:10.1016/ S0168-3659(00)00339-4
45. Sun JB, Duan JH, Dai SL, Ren J, Zhang YD, Tian JS, Li Y (2007) In vitro and in vivo antitumor effects of doxorubicin loaded with bacterial magnetosomes (DBMs) on H22 cells: the magnetic bio-nanoparticles as drug carriers. Cancer Lett 258:109-117. doi:10.1016/j.canlet.2007.08.018
46. Tanaka K, Ito A, Kobayashi T, Kawamura T, Shimada S, Matsumoto K, Saida T, Honda H (2005) Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma. J Biosci Bioeng 100:112-115. doi: 10.1263/jbb.100.112
47. Tashjian JA, Dewhirst MW, Needham D, Viglianti BL (2008) Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques. Int J Hyperth 24:79-90. doi:10.1080/02656730701840147
48. Thanoo BC, Sunny MC, Jayakrishnan A (1992) Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J Pharm Pharmacol 44:283-286
49. Torchilin VP (2006) Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532-1555. doi:10.1016/j.addr.2006.09.009
50. van Oss CJ (2006) Interfacial forces in aqueous media, 2nd edn. CRC Press, Boca Raton, FL